Target intelligence / Profile preview

Vacuolar-type H+-ATPase subunit c (ATP6V0C) (ATP6V0C)

Target
ATP6V0C
Molecular classification
Enzyme, Transporter, Proton pump, ATPase
01

Overview

The Vacuolar-type H+-ATPase (V-ATPase) is a highly conserved, multi-subunit enzyme complex that functions as an ATP-driven proton pump, primarily responsible for the acidification of intracellular compartments such as lysosomes, endosomes, and the Golgi apparatus [UniProt P27449]. The Vo c-subunit is a fundamental component of the membrane-integral Vo domain, where it forms a proteolipid ring that rotates to translocate protons across the lipid bilayer [PubMed: 17203062]. This acidification is essential for diverse biological processes, including the activation of lysosomal hydrolases, receptor-mediated endocytosis, and the coupled transport of neurotransmitters [PubMed: 18606446]. In disease states, V-ATPase is often dysregulated; for example, its overexpression on the plasma membrane of cancer cells facilitates an acidic tumor microenvironment that promotes protease activation and metastasis [PubMed: 25613000]. Additionally, it is critical for bone resorption by osteoclasts and serves as a gateway for the entry of various pH-dependent viruses [PubMed: 20530212]. While the c-subunit is a potent target for inhibitors like bafilomycin A1, the ubiquitous necessity of V-ATPase for cellular viability presents significant challenges for achieving therapeutic selectivity and minimizing systemic toxicity [PubMed: 20433182].

Other names
V-type proton ATPase subunit cV-ATPase 16 kDa proteolipid subunitATP6CATP6LVPATPCVacuolar proton pump subunit cATPase H+ transporting V0 subunit c
02

Mechanism of action

Inhibition of the proton-translocating Vo domain by binding to the c-subunit ring, thereby blocking the rotational mechanism required for proton transport across the membrane.

03

Biological functions

Acidification of intracellular compartmentsIntracellular pH homeostasisBone resorptionNeurotransmitter loadingProtein degradationReceptor-mediated endocytosisProtein trafficking
04

Disease associations

CancerOsteoporosisViral infectionNeurodegenerative diseaseRenal tubular acidosis
05

Safety considerations

Systemic toxicity due to ubiquitous expressionLysosomal dysfunctionImpaired protein degradationPotential for systemic acidosisOff-target effects on essential cellular pH regulation
06

Interacting drugs

Bafilomycin A1

5 more in the full profile.

07

Biomarkers

Lysosomal pHCathepsin activityUrinary pHC-terminal telopeptide (CTx)N-terminal telopeptide (NTx)

Beyond the preview

Go deeper on Vacuolar-type H+-ATPase subunit c (ATP6V0C) (ATP6V0C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar-type H+-ATPase subunit c (ATP6V0C) (ATP6V0C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call